+971 52 248 8528
+966 56 233 0183
Saudi Arabia is set to host the Middle East edition of the BIO / CPHI Biotechnology and Pharmaceutical Development Forum in Riyadh, reinforcing the Kingdom’s growing role as a regional hub for healthcare innovation and pharmaceutical investment.
The forum will take place from May 11 to May 13 at the Riyadh International Convention and Exhibition Center under the patronage of the Ministry of Health Saudi Arabia and organized by Tahaluf Company.
Global Platform for Biotechnology and Pharmaceutical Development
The BIO / CPHI forum is expected to attract more than 60,000 participants from over 100 countries, along with over 1,000 global brands involved in biotechnology, pharmaceuticals, healthcare innovation, and medical research.
The event will serve as a major global platform for collaboration, knowledge exchange, and partnership development, bringing together industry leaders, researchers, investors, and policymakers to explore opportunities in the rapidly evolving biotech and pharmaceutical sectors.
Supporting Saudi Vision 2030
Hosting the BIO / CPHI forum reflects the Kingdom’s commitment to strengthening its healthcare sector and advancing innovation as part of Saudi Vision 2030.
Through initiatives like this forum, Saudi Arabia aims to:
Localize pharmaceutical manufacturing
Increase healthcare sector contribution to GDP
Expand healthcare investments
Develop national healthcare talent
Enhance global collaboration in biotechnology and life sciences
The event highlights the Kingdom’s readiness to become a regional leader in biotechnology and pharmaceutical development, supported by a favorable regulatory environment and strong government backing.
Growing Opportunities for Healthcare Investors
Saudi Arabia’s healthcare and life sciences sectors are rapidly expanding, creating significant opportunities for international companies, research institutions, and pharmaceutical manufacturers. With increased government investment and supportive policies, the Kingdom continues to attract global attention in biotechnology and medical innovation.
How J K Supports Healthcare Businesses
For international companies looking to enter Saudi Arabia’s healthcare and pharmaceutical markets, J K Management Consultancies provides expert guidance and business support services.
Our services include:
Company Formation in Saudi Arabia
SFDA Product Registration
Regulatory Compliance and Licensing
Vendor Registration for Government and Mega Projects
Business Expansion Advisory
With extensive experience supporting foreign investors, J K Management Consultancy helps healthcare and biotech companies successfully establish and grow in Saudi Arabia’s rapidly evolving market.
Planning to start or expand your pharmaceutical or biotech business in Saudi Arabia?
Contact J K Management Consultancies for expert support in entering the Kingdom’s growing healthcare sector.
